Uncategorized

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand – CNBC

Posted on Author Tim Hodges Comments Off on Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand – CNBC
  1. Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand  CNBC
  2. Eli Lilly shares tumble after cutting its sales outlook. What it means for investors  CNBC
  3. Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday  Yahoo Finance
  4. Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping  MarketWatch
  5. Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow  Investor’s Business Daily